Innohep Alert Sounded, But This Time Heparin Not Sourced From China
This article was originally published in The Pink Sheet Daily
Executive Summary
Preliminary data do not suggest a manufacturing problem, but FDA’s ongoing safety review notes the heparin used is still under investigation.